Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Iavicoli

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Acta Endocrinologica|February 1, 1982
Circulating immune complexes in diabetics with severe microangiopathy: evaluation by two different methodsD Andreani, U Di Mario, C Galfo, et al.
Diabetologia|January 1, 1983
Aspects of humoral immunity in a prospective study of Type I (insulin-dependent) diabetic subjects treated with insulins of different purityM Iavicoli, L Ventriglia, U Di Mario, et al.
Minerva Endocrinologica|April 1, 1984
[Insulin antibodies and immune complexes in long-term diabetics switched to monocomponent human insulin]M Iavicoli, U Di Mario, G A Coronel, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1995
Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatmentR Valcavi, O Gaddi, M Zini, et al.
Diabetes Research (Edinburgh, Scotland)|September 1, 1988
Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulinsF Virgili, F Frigato, P G Magnanini, et al.
Diabetes|January 1, 1982
Impaired phagocytic function and increased immune complexes in diabetics with severe microangiopathyM Iavicoli, U Di Mario, P Pozzilli, et al.
Immunology Letters|January 1, 1984
Lymphocyte subsets and immune complexes in long-standing diabetic patients: relation with the presence of microangiopathyD Andreani, U Di Mario, O Zuccarini, et al.
Journal of Clinical & Laboratory Immunology|May 1, 1983
Circulating immune complexes in diabetics: the influence of sex, age, duration of disease and type of treatmentU Di Mario, W J Irvine, K Guy, et al.
Diabetes Care|March 1, 1984
Semisynthetic human insulin: biologic and immunologic activity in newly treated diabetic subjects during a six-month follow-upM Iavicoli, U Di Mario, G A Coronel, et al.
Journal of Clinical & Laboratory Immunology|November 1, 1978
Immune complexes and diabetic microangiopathyW J Irvine, U Di Mario, K Guy, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Acta Endocrinologica|February 1, 1982
Circulating immune complexes in diabetics with severe microangiopathy: evaluation by two different methodsD Andreani, U Di Mario, C Galfo, et al.
Diabetologia|January 1, 1983
Aspects of humoral immunity in a prospective study of Type I (insulin-dependent) diabetic subjects treated with insulins of different purityM Iavicoli, L Ventriglia, U Di Mario, et al.
Minerva Endocrinologica|April 1, 1984
[Insulin antibodies and immune complexes in long-term diabetics switched to monocomponent human insulin]M Iavicoli, U Di Mario, G A Coronel, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1995
Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatmentR Valcavi, O Gaddi, M Zini, et al.
Diabetes Research (Edinburgh, Scotland)|September 1, 1988
Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulinsF Virgili, F Frigato, P G Magnanini, et al.
Diabetes|January 1, 1982
Impaired phagocytic function and increased immune complexes in diabetics with severe microangiopathyM Iavicoli, U Di Mario, P Pozzilli, et al.
Immunology Letters|January 1, 1984
Lymphocyte subsets and immune complexes in long-standing diabetic patients: relation with the presence of microangiopathyD Andreani, U Di Mario, O Zuccarini, et al.
Journal of Clinical & Laboratory Immunology|May 1, 1983
Circulating immune complexes in diabetics: the influence of sex, age, duration of disease and type of treatmentU Di Mario, W J Irvine, K Guy, et al.
Diabetes Care|March 1, 1984
Semisynthetic human insulin: biologic and immunologic activity in newly treated diabetic subjects during a six-month follow-upM Iavicoli, U Di Mario, G A Coronel, et al.
Journal of Clinical & Laboratory Immunology|November 1, 1978
Immune complexes and diabetic microangiopathyW J Irvine, U Di Mario, K Guy, et al.
Pageof 3